Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 07, 2019

SELL
$59.47 - $93.1 $95,687 - $149,797
-1,609 Closed
0 $0
Q2 2019

Aug 08, 2019

BUY
$75.84 - $105.21 $13,196 - $18,306
174 Added 12.13%
1,609 $205,000
Q1 2019

May 10, 2019

BUY
$64.44 - $104.11 $92,471 - $149,397
1,435 New
1,435 $226,000

Others Institutions Holding BLUE

About bluebird bio, Inc.


  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $27M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Sawtooth Solutions, LLC Portfolio

Follow Sawtooth Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sawtooth Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sawtooth Solutions, LLC with notifications on news.